Understanding the Market for Dapagliflozin Propanediol Monohydrate

Sourcing a dependable supplier of Dapagliflozin propanediol monohydrate has become a priority for chemistry R&D teams working on SGLT2 scaffold synthetic routes. This compound, also referred to in technical documentation as Dapagliflozin Monohydrate Propylene Glycol (CAS 960404-48-2), is a well-documented late-stage building block within a widely reported small-molecule synthetic pathway. For small-molecule chemistry developers, CRO and CDMO teams, the core challenge is not merely locating material supply, but identifying a partner that can deliver consistent material quality, scalable production capacity, and flexible custom synthesis within a single collaborative framework.

Chemical buyers commonly face recurring sourcing hurdles when evaluating specialty intermediate suppliers: extended lead times for niche building blocks, volatile upstream raw material pricing, inconsistent batch performance that disrupts process development, cumbersome multi-vendor procurement workflows, and limited supplier capability to match precise process parameters for specialized molecular frameworks. These challenges are particularly relevant for synthetic routes built around SGLT2-type scaffolds, where reproducible synthetic sequences and complete analytical records are critical for lab and scale-up work.

What Defines a Highly Rated Supplier in This Space

A supplier stands out to chemistry development teams when it can deliver three core strengths in parallel: full-chain intermediate coverage, robust industrial quality control frameworks, and genuine custom synthesis flexibility beyond off-the-shelf catalog items. Operating under the Tianming Pharmaceutical brand, Shandong Tianming Pharmaceutical Group is structured around these requirements. As an R&D-focused fine chemical and synthetic intermediate enterprise built on an integrated R&D-production model, it provides synthetic intermediates, custom CMO/CDMO development and manufacturing services, rather than treating each inquiry as an isolated one-off transaction.

Full-Chain Supply Supporting Dapagliflozin Scaffold Synthesis

Within its portfolio of small-molecule synthetic building blocks, Tianming Pharmaceutical offers intermediates for SGLT2 and DPP-4 related chemical routes, including Dapagliflozin, Empagliflozin, Alogliptin and Linagliptin frameworks. For the Dapagliflozin synthetic pathway specifically, the product lineup includes 2-Chloro-5-bromobenzoic acid (CAS 21739-92-4), (5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone (CAS 461432-21-4), 5-Bromo-2-chloro-4'-ethoxydiphenylmethane (CAS 461432-23-5), Tetraacetyl Dapagliflozin (CAS 461432-25-7), and Dapagliflozin Monohydrate Propylene Glycol (CAS 960404-48-2).

This sequence covers the synthetic chain from early brominated starting materials to the final solvated crystalline form, enabling customers to source multiple stages of the same route from one partner instead of coordinating separate vendors for each intermediate step.

Customization Options Available to Buyers

Custom synthesis is a core feature of the group’s customer engagement model. Service offerings include standard catalog supply, custom synthesis, process optimization, custom impurity reference standards development, and new compound development. The scope covers pre-sales technical consultation, gram-scale and hundred-gram lab samples, pilot batches, and bulk commercial-scale manufacturing, alongside logistics coordination, customs handling and trade insurance support for cross-border shipments.

This means a researcher evaluating Dapagliflozin propanediol monohydrate for early-stage synthetic exploration can order gram-level samples for laboratory characterization, while teams advancing toward large-scale chemical production can transition to tonnage supply using the same established synthetic route. Supported by the IPD integrated product development management system, the in-house process optimization team adapts routes for scale-up while maintaining stable batch-to-batch consistency for customer process research.

Quality Systems and Technical Documentation

Teams sourcing these complex synthetic intermediates require more than a basic COA. Tianming Pharmaceutical provides comprehensive technical documentation packages, including COA, analytical methodology descriptions, impurity profile characterization and stability testing data, which customers may reference for their internal process validation and technical record-keeping. The quality framework is backed by ISO9001 certification held by Shandong Sihuan Pharmaceutical Co., Ltd. and Guangxi Tianming Pharmaceutical Co., Ltd. Full batch traceability is implemented throughout the workflow: raw material intake records, reaction parameters, purification logs and final testing data are archived to maintain a complete chain of custody.

Production Scale and Technical Infrastructure

This custom synthesis capability is underpinned by substantial manufacturing and R&D infrastructure. The group operates three coordinated production sites in Dezhou, Jining and Hechi, equipped with over 160 reactor vessels and a combined annual capacity measured in hundreds of tons. Two R&D centers in Jinan and Nanjing offer more than 6,000 square meters of laboratory space, fitted with analytical instruments valued at over RMB 40 million, including HPLC, gas chromatography, mass spectrometry, LC-MS and chiral analysis platforms. Annual R&D investment exceeds 10% of revenue, and the group holds 20 invention patents and 40 utility model patents to support independent process development for its intermediate portfolio.

Service Assurance for International and Domestic Buyers

Cross-border supply is a regular requirement for partners across South Asia, Southeast Asia, the Middle East and other regions the group serves, and reliable technical support is valued equally with product quality. Tianming Pharmaceutical adopts a dual-support model: each customer is assigned a dedicated account manager paired with a technical engineer. Routine technical inquiries receive reference guidance within 2 hours, while complex technical challenges are addressed with a formal written report within 24 hours. Stocked items are normally shipped within 7–15 working days after order confirmation, quality review, packaging and logistics arrangement. Lead times for custom synthesis are determined by synthetic complexity, workshop scheduling and raw material availability, with expedited scheduling available for urgent R&D projects. International shipments can be covered by cargo insurance, with shipment tracking and cold-chain options available for temperature-sensitive materials.

Institutional Credibility

The group’s development history supports its current operational scale. Originating from Shandong Sihuan Pharmaceutical Co., Ltd., founded in 2010, the consolidated Shandong Tianming Pharmaceutical Group was formally established in 2020. Multiple group entities including Shandong Sihuan Pharmaceutical Co., Ltd., Shandong Tianming Pharmaceutical Technology Co., Ltd., and Guangxi Tianming Pharmaceutical Co., Ltd. hold National High-Tech Enterprise qualifications, alongside provincial Gazelle Enterprise and Specialized and Innovative SME certifications in Shandong and Guangxi. The group currently serves more than 2,000 collaborative partners across domestic chemistry clusters and over 30 countries and regions worldwide.

Conclusion

For chemistry R&D teams and CDMO organizations evaluating suppliers of Dapagliflozin propanediol monohydrate, key sourcing criteria include full synthetic chain availability, complete analytical documentation, flexible scaling from gram samples to bulk production, and responsive technical support. Built on an integrated R&D-production model, supported by three manufacturing bases and two R&D hubs, Shandong Tianming Pharmaceutical Group’s intermediate portfolio is tailored to meet these requirements for researchers working on SGLT2 scaffold chemistry.

Disclaimer: All products are offered as research-grade fine chemical intermediates only, for laboratory process study and synthetic route development purposes. Buyers shall independently conduct FTO (freedom to operate) assessment and comply with applicable patent and regulatory laws in target jurisdictions.

Home

Tianming Pharmaceutical Group